Evolution Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9K Sell
30
-4
-12% -$1.37K 0.01% 563
2026
Q1
$12K Buy
34
+5
+17% +$1.78K 0.01% 489
2025
Q4
$9.49K Buy
+29
New +$9.2K 0.01% 452
2025
Q3
Sell
-36
Closed -$9.92K 597
2025
Q2
$9.92K Buy
+36
New +$10.2K 0.01% 362

Other funds holding AMGN

Evolution Wealth Management's AMGN Position: Q2 2026 in Review

Evolution Wealth Management reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $1.37K and leaving 30 shares worth $10.9K. The position accounts for 0.01% of the portfolio, ranked #563.

Evolution Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $12K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Evolution Wealth Management held 30 shares of Amgen worth $10.9K as of Q2 2026.
  • Evolution Wealth Management sold 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.01% of Evolution Wealth Management's portfolio in Q2 2026, its #563 holding.
  • Evolution Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • Evolution Wealth Management's Amgen position peaked at $12K in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.